Cell : The Lancet - Translational Medicine

Speaker

Steven G. DEEKS, University of California, San Francisco, USA

Steven G. DEEKS“Antiretroviral therapy has turned HIV infection from a nearly universal fatal infection into a chronic disease marked by increased risk of a series of age-related conditions, including heart disease, bone disease and a variety of cancers. Why these conditions are happening at higher than expected rates and how these conditions might impact healthy aging is the focus of intense research.”

Steven G. Deeks, MD, is a Professor of Medicine in Residence at the University of California, San Francisco (UCSF) and a faculty member at San Francisco General Hospital.  Dr. Deeks has been engaged in HIV research and clinical care since 1993.  He is a recognized expert on the role of chronic inflammation in untreated and treated HIV disease.  His work currently focuses on determining the cause and consequences of HIV-associated inflammation. Dr. Deeks has published over 250 peer-review articles, editorials and invited reviews on these and related topics. He has been the recipient of several NIH grants, and is a principle investigator of DARE, which is an international NIH-sponsored collaboratory aimed at developing therapeutic interventions to cure HIV infection. In addition He is the co-chair of the “Towards an HIV Cure” International Working Group. He is also a member of the Office of AIDS Research Advisory Council (ORAC) and was elected to the American Society for Clinical Investigation (ASCI). In addition to his clinical and translational investigation, Dr. Deeks maintains a primary care clinic for HIV infected patients, and is a member of the Department on Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents.

« Go Back

Organized by

Elsevier
Journal - The Lancet
Journal - Cell
Elsevier

Partners

Timothy Ray Brown
World AIDS Institute